Davis Polk advised the joint bookrunners in connection with the primary and secondary public offering by Aeris Indústria e Comércio de Equipamentos para Geração de Energia S.A. and the…
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $4.5 billion aggregate principal amount of senior notes, consisting of $1.75 billion fixed-to…
Davis Polk advised the underwriter in connection with a block trade of 663,394 shares of Class A common stock of Bandwidth Inc. by VIP II Nominees Limited (for the benefit of Vitruvian…
Davis Polk advised the lead manager, sole book-runner and representative of the several underwriters in connection with Bank of America Corporation’s 1.1 billion SEC-registered…
Davis Polk advised the lead manager, sole book-runner and representative of the several underwriters in connection with an SEC-registered offering by Bank of America Corporation of …
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of €1.75 billion aggregate principal amount of fixed-to-floating-rate senior notes due 2029. …
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $1 billion aggregate principal amount of fixed-to-floating-rate senior notes due 2025. During the…
Davis Polk advised the representative of the initial purchasers of a Rule 144A/Regulation S offering by Acadia Healthcare Company, Inc. of $475 million aggregate principal amount of…
Davis Polk advised the joint book-running managers in connection with a $216.2 million public offering of 5,750,000 shares of common stock by NanoString Technologies, Inc., which…
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering of 5,750,000 common shares of Beam Therapeutics Inc. for total gross proceeds of $127…